Catalyst Wire Dossier Catalyst Wire Dossier

iron isomaltoside (intravenous)

iron isomaltoside · Pharmacosmos A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for iron isomaltoside (intravenous), covering 2020-11-13 to 2020-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy. [Phase 4]

See pricing